HRTX insider transaction filings
HERON THERAPEUTICS, INC. /DE/ — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-10. Screen HRTX transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-10 | 4 | Hensley Mark Earl — Chief Operating Officer | Option exercise (M): 31,250 · Tax withholding (F): 8,888 @ $0.50 · Option exercise (M): 31,250 (derivative) @ $0 | EDGAR |
| 2026-08-03 | 4 | Hensley Mark Earl — Chief Operating Officer | Option exercise (M): 11,769 · Option exercise (M): 11,769 (derivative) @ $0 | EDGAR |
| 2026-08-03 | 4 | Forbes William P — EVP, Chief Development Officer | Option exercise (M): 11,769 · Tax withholding (F): 3,348 @ $0.50 · Option exercise (M): 11,694 · Tax withholding (F): 3,326 @ $0.50 · Option exercise (M): 11,769 (derivative) @ $0 · Option exercise (M): 11,694 (derivative) @ $0 | EDGAR |
| 2026-08-03 | 4 | Duarte Ira — EVP, Chief Financial Officer | Option exercise (M): 13,535 · Tax withholding (F): 3,850 @ $0.50 · Option exercise (M): 11,694 · Tax withholding (F): 3,326 @ $0.50 · Option exercise (M): 13,535 (derivative) @ $0 · Option exercise (M): 11,694 (derivative) @ $0 | EDGAR |
| 2026-08-03 | 4 | Collard Craig A — Chief Executive Officer, Director | Option exercise (M): 50,021 · Option exercise (M): 34,789 · Option exercise (M): 50,021 (derivative) @ $0 · Option exercise (M): 34,789 (derivative) @ $0 | EDGAR |
| 2026-07-20 | 4 | Duarte Ira — EVP, Chief Financial Officer | Option exercise (M): 3,874 · Tax withholding (F): 1,101 @ $0.47 · Option exercise (M): 3,874 (derivative) @ $0 | EDGAR |
| 2026-07-20 | 4 | Collard Craig A — Chief Executive Officer, Director | Option exercise (M): 13,797 · Option exercise (M): 13,797 (derivative) @ $0 | EDGAR |
| 2026-07-20 | 4 | Forbes William P — EVP, Chief Development Officer | Option exercise (M): 3,874 · Tax withholding (F): 1,101 @ $0.47 · Option exercise (M): 3,874 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | Duarte Ira — EVP, Chief Financial Officer | Option exercise (M): 12,500 · Tax withholding (F): 3,555 @ $0.38 · Option exercise (M): 12,500 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | Forbes William P — EVP, Chief Development Officer | Option exercise (M): 12,500 · Option exercise (M): 12,500 (derivative) @ $0 | EDGAR |
| 2026-05-07 | 4 | Hensley Mark Earl — Chief Operating Officer | Option exercise (M): 125,000 · Option exercise (M): 125,000 (derivative) @ $0 | EDGAR |
| 2026-05-04 | 4 | Hensley Mark Earl — Chief Operating Officer | Option exercise (M): 11,770 · Option exercise (M): 11,770 (derivative) @ $0 | EDGAR |
| 2026-05-04 | 4 | Duarte Ira — EVP, Chief Financial Officer | Option exercise (M): 11,694 · Option exercise (M): 13,535 · Option exercise (M): 11,694 (derivative) @ $0 · Option exercise (M): 13,535 (derivative) @ $0 | EDGAR |
| 2026-05-04 | 4 | Collard Craig A — Chief Executive Officer, Director | Option exercise (M): 34,789 · Option exercise (M): 50,021 · Option exercise (M): 34,789 (derivative) @ $0 · Option exercise (M): 50,021 (derivative) @ $0 | EDGAR |
| 2026-05-04 | 4 | Forbes William P — EVP, Chief Development Officer | Option exercise (M): 11,694 · Option exercise (M): 11,770 · Option exercise (M): 11,694 (derivative) @ $0 · Option exercise (M): 11,770 (derivative) @ $0 | EDGAR |
| 2026-04-21 | 4 | Duarte Ira — EVP, Chief Financial Officer | Option exercise (M): 3,874 · Option exercise (M): 3,874 (derivative) @ $0 | EDGAR |
| 2026-04-21 | 4 | Collard Craig A — Chief Executive Officer, Director | Option exercise (M): 13,797 · Option exercise (M): 13,797 (derivative) @ $0 | EDGAR |
| 2026-04-21 | 4 | Forbes William P — EVP, Chief Development Officer | Option exercise (M): 3,874 · Option exercise (M): 3,874 (derivative) @ $0 | EDGAR |
| 2026-04-06 | 4 | Collard Craig A — Chief Executive Officer, Director | Option exercise (M): 62,500 · Option exercise (M): 62,500 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | Cusack Thomas — Director | Grant/award (A): 53,960 @ $0 | EDGAR |
| 2026-02-03 | 4 | Hensley Mark Earl — Chief Operating Officer | Grant/award (A): 188,315 (derivative) @ $0 · Grant/award (A): 188,314 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | Morgan Adam — Director | Grant/award (A): 53,960 @ $0 | EDGAR |
| 2026-02-03 | 4 | Dissanaike Sharmila — Director | Grant/award (A): 53,960 @ $0 | EDGAR |
| 2026-02-03 | 4 | Kaseta Michael — Director | Grant/award (A): 53,960 @ $0 | EDGAR |
| 2026-02-03 | 4 | Christian Waage — Director | Grant/award (A): 53,960 @ $0 | EDGAR |
| 2026-02-03 | 4 | Duarte Ira — EVP, Chief Financial Officer | Grant/award (A): 216,562 (derivative) @ $0 · Grant/award (A): 216,561 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | Duarte Ira — EVP, Chief Financial Officer | Option exercise (M): 11,695 · Option exercise (M): 11,695 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | Johnson Craig A — Director | Grant/award (A): 53,960 @ $0 | EDGAR |
| 2026-02-03 | 4 | Collard Craig A — Chief Executive Officer, Director | Grant/award (A): 800,337 (derivative) @ $0 · Grant/award (A): 800,336 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | Collard Craig A — Chief Executive Officer, Director | Option exercise (M): 34,789 · Option exercise (M): 34,789 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | Forbes William P — EVP, Chief Development Officer | Grant/award (A): 188,315 (derivative) @ $0 · Grant/award (A): 188,314 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | Forbes William P — EVP, Chief Development Officer | Option exercise (M): 11,695 · Option exercise (M): 11,695 (derivative) @ $0 | EDGAR |
| 2026-01-20 | 4 | Duarte Ira — EVP, Chief Financial Officer | Option exercise (M): 3,875 · Option exercise (M): 3,875 (derivative) @ $0 | EDGAR |
| 2026-01-20 | 4 | Collard Craig A — Chief Executive Officer, Director | Option exercise (M): 13,797 · Option exercise (M): 13,797 (derivative) @ $0 | EDGAR |
| 2026-01-20 | 4 | Forbes William P — EVP, Chief Development Officer | Option exercise (M): 3,875 · Option exercise (M): 3,875 (derivative) @ $0 | EDGAR |
| 2025-11-12 | 4 | Cusack Thomas — Director | Grant/award (A): 37,879 · Grant/award (A): 227,272 (derivative) @ $1.10 | EDGAR |
| 2025-11-04 | 4 | Duarte Ira — EVP, Chief Financial Officer | Option exercise (M): 11,694 · Option exercise (M): 11,694 (derivative) @ $0 | EDGAR |
| 2025-11-04 | 4 | Collard Craig A — Chief Executive Officer, Director | Option exercise (M): 34,789 · Option exercise (M): 34,789 (derivative) @ $0 | EDGAR |
| 2025-11-04 | 4 | Forbes William P — EVP, Chief Development Officer | Option exercise (M): 11,694 · Option exercise (M): 11,694 (derivative) @ $0 | EDGAR |
| 2025-10-21 | 4 | Duarte Ira — EVP, Chief Financial Officer | Option exercise (M): 3,874 · Option exercise (M): 3,874 (derivative) @ $0 | EDGAR |
| 2025-10-21 | 4 | Collard Craig A — Chief Executive Officer, Director | Option exercise (M): 13,797 · Option exercise (M): 13,797 (derivative) @ $0 | EDGAR |
| 2025-10-21 | 4 | Forbes William P — EVP, Chief Development Officer | Option exercise (M): 3,874 · Option exercise (M): 3,874 (derivative) @ $0 | EDGAR |
| 2025-10-17 | 4 | Rubric Capital Management LP — 10% owner Rosen David Efraim — 10% owner | Conversion (C): 946,100 · Conversion (C): 94,610 (derivative) @ $0 | EDGAR |
| 2025-08-12 | 4 | Morgan Adam — Director | Purchase (P): 1,766,546 @ $1.50 · Purchase (P): 70,012 (derivative) @ $15 | EDGAR |
| 2025-08-12 | 4 | Rubric Capital Management LP — 10% owner Rosen David Efraim — 10% owner | Purchase (P): 2,387,225 @ $1.50 · Purchase (P) @ $33,250,000 · Purchase (P): 94,610 (derivative) @ $15 | EDGAR |
| 2025-08-04 | 4 | Duarte Ira — EVP, Chief Financial Officer | Option exercise (M): 11,695 · Option exercise (M): 11,695 (derivative) @ $0 | EDGAR |
| 2025-08-04 | 4 | Collard Craig A — Chief Executive Officer, Director | Option exercise (M): 34,789 · Option exercise (M): 34,789 (derivative) @ $0 | EDGAR |
| 2025-08-04 | 4 | Forbes William P — EVP, Chief Development Officer | Option exercise (M): 11,695 · Option exercise (M): 11,695 (derivative) @ $0 | EDGAR |
| 2025-07-22 | 4 | Duarte Ira — EVP, Chief Financial Officer | Option exercise (M): 3,874 · Option exercise (M): 3,874 (derivative) @ $0 | EDGAR |
| 2025-07-22 | 4 | Collard Craig A — Chief Executive Officer, Director | Option exercise (M): 13,797 · Option exercise (M): 13,797 (derivative) @ $0 | EDGAR |
Recent 8-K events — HERON THERAPEUTICS, INC. /DE/
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-14 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.03 — Material Modification to Rights of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-10 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-25 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-16 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-06-02 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-11 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-06 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-26 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-09 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-04 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=HRTX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →